Status:
COMPLETED
Relation Between the Value of Platelet Clot Stiffness (PCS) Obtained by Sonorheometric Method of Delocalized Hemostasis (QUANTRA®), and the Presence of a Disorder of Primary Hemostasis, in Cardiac Surgery Patients. PLAQUA-Study
Lead Sponsor:
Centre Hospitalier Universitaire de la Réunion
Conditions:
Primary Haemostasis Disorder in Cardiac Surgery Patients
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this study is to determine whether the Platelet Clot Stiffness (PCS) measured by QUANTRA® is predictive of an abnormality in primary haemostasis intraoperatively in cardiac surgery perform...
Eligibility Criteria
Inclusion
- Patients
- Hospitalized for scheduled cardiac surgery performed under extracorporeal circulation, including coronary bypass, valve replacement, aortic arch and combined surgeries.
Exclusion
- Patients:
- with preoperative hematocrit \< 35% and preoperative platelet count \< 80,000 G/L (validity of PFA-200® Test)
- With known congenital or acquired Willebrand's disease, or known platelet dysfunction.
- On double antiaggregation, not discontinued at the time of surgery
- Vulnerable patients: minors or protected adults, pregnant women, patients not affiliated to the social security system.
- Emergency situation
Key Trial Info
Start Date :
August 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 4 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06585930
Start Date
August 30 2024
End Date
April 4 2025
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Reunion Island - Cardiac reanimation department
Saint-Denis, Réunion, Reunion, 97400